Ewing sarcomaEEwing sarcomaEwing sarcomaEnglishOncologyPre-teen (9-12 years);Teen (13-18 years)Legs;Arm;Back;Chest;PelvisSkeletal systemConditions and diseasesAdult (19+) CaregiversNA2018-11-08T05:00:00ZAbha Gupta, MD, MSc, FRCPC9.7000000000000048.0000000000000823.000000000000Health (A-Z) - ConditionsHealth A-Z<p>Ewing sarcoma is a type of cancer that can start in bone and sometimes soft tissue. It is most commonly found in children, teens and young adults. Learn about the signs and symptoms and how it is diagnosed and treated.</p><h2>What is Ewing sarcoma?</h2><p>Ewing sarcoma is a rare type of cancer which can affect any bone and sometimes soft tissue. The bones most commonly affected are the leg and arm bones, pelvis, ribs, spine and sternum. Ewing sarcoma is seen most often in pre-teens, adolescents and young adults between the ages of 10 and 20. In patients where the cancer has not spread the five-year survival rate is greater than 70%.</p><h2>Key points</h2><ul><li>Ewing sarcoma is a rare type of cancer affecting bones or soft tissue.</li><li>It is most commonly found in children, teens and young adults between ages 10 and 20.</li><li>The most common symptom of Ewing sarcoma is pain (especially when it starts in the bone).</li><li>This pain may initially be thought to be related to sports injury, growing pains or an inflammatory condition.</li></ul> <h2>Symptoms of Ewing sarcoma</h2><p>Symptoms of Ewing sarcoma include:</p><ul><li>swelling or a lump at the site of the tumour</li><li>pain near the site of the tumour</li><li>pain from an injury that is greater than expected and does not get better with time</li></ul><p>Often patients are very well except for a painful bump.</p><h2>What causes Ewing sarcoma?</h2><p>There is currently no known cause for Ewing sarcoma. It is not hereditary. It is the second most common primary bone tumour.</p><h2>Who gets Ewing sarcoma?</h2><p>Ewing sarcoma is most commonly seen in pre-teens, adolescents and young adults between the ages of 10 and 20.</p><h2>Diagnosing Ewing sarcoma</h2><p>Initially, the symptoms of Ewing sarcoma can be diagnosed as a sports injury, growing pains or an inflammatory condition. However, if symptoms cannot be fully explained, persist or change rapidly, see your doctor immediately for further assessment.</p><p>Your child’s doctor will do a complete history and physical examination that includes:</p><ul><li>if there is a lump or swelling, and whether it has changed in size</li><li>the amount of pain, whether it is constant or increasing in intensity</li><li>if there is an unexplained limp or problem using their limbs</li></ul><p>Your child’s doctor will order X-rays, a CT scan or an MRI of the area of concern.</p><p>A biopsy of the mass will be done to confirm the diagnosis.</p><p>To check to see if the cancer has spread, a CT scan of the lungs and a scan of the bones will also be done.</p> <h2>Treatment for Ewing sarcoma</h2><p>The standard treatment for Ewing sarcoma includes both chemotherapy as well as some form of local control. Local control includes either surgery or radiation or both. The chemotherapy generally lasts for 28 to 30 weeks in total. Both chemotherapy and local control are needed in order to treat Ewing sarcoma. There are both short-term and long-term side effects of the treatment.</p><h2>Resources</h2><p>For additional information about Ewing sarcoma please visit the following resources.</p><ul><li>Find more information about Ewing sarcoma at the <a href="https://www.cancer.gov/types/bone/patient/ewing-treatment-pdq">National Cancer Institute</a>.</li><li>Read an article about <a href="http://www.sickkids.ca/aboutsickkids/newsroom/past-news/2018/bone-cancers-hidden-years-before-diagnosis.html">how children’s bone cancers could remain hidden for years before diagnosis</a>.</li><li>A <a href="https://assets.aboutkidshealth.ca/AKHAssets/Ewings%20Sarcoma%20Brochure.pdf">guide for physicians</a> providing information about Ewing sarcoma.</li></ul> <figure class="asset-small"> <a href="https://www.sickkidsfoundation.com/ewingscancerfoundation"> <img src="https://assets.aboutkidshealth.ca/akhassets/Ewings%20cancer%20logo%20300.jpg" alt="" /></a> </figure> <p>This page was supported and created in collaboration with the <a href="https://www.sickkidsfoundation.com/ewingscancerfoundation">Ewings Cancer Foundation of Canada</a>.</p><h2>References</h2><ol><li>The Canadian Childhood Cancer Surveillance and Control Program. (August 2004). <em>Diagnosis and Initial Treatment of Cancer in Canadian Adolescents 15 to 19 Years of Age, 1995–2000</em>. Retrieved from <a href="http://publications.gc.ca/collections/Collection/H39-4-38-2004E.pdf">http://publications.gc.ca/collections/Collection/H39-4-38-2004E.pdf</a></li><li>Public Health Agency of Canada. (October 2017). <em>Cancer in Young People in Canada: A Report from the Enhanced Childhood Cancer Surveillance System</em>. Retrieved from <a href="https://www.canada.ca/content/dam/hc-sc/documents/services/publications/science-research-data/cancer-young-people-canada-surveillance-2017-eng.pdf">https://www.canada.ca/content/dam/hc-sc/documents/services/publications/science-research-data/cancer-young-people-canada-surveillance-2017-eng.pdf</a></li><li>George, G., and Grimer, R. (2012). Early symptoms of bone and soft tissue sarcomas: could they be diagnosed earlier? <em>Annals of The Royal College of Surgeons of England, 94</em>, 261-266. doi: <a href="https://dx.doi.org/10.1308/003588412X13171221590016">10.1308/003588412X13171221590016</a></li><li>Grimer, R.J., and Briggs, T.W. (2010). Earlier diagnosis of bone and soft-tissue tumours. <em>The Journal of bone and joint surgery. British volume, 92</em>, 1489-92. doi: <a href="https://doi.org/10.1302/0301-620X.92B11.24326">10.1302/0301-620X.92B11.24326</a></li><li>Borinstein, S.C., Beeler, N., and Block, J.J., et al. (2013). A Decade in Banking Ewing Sarcoma: A Report from the Children's Oncology Group. <em>Frontiers in oncology, 3</em>, 57. doi: <a href="https://dx.doi.org/10.3389/fonc.2013.00057">10.3389/fonc.2013.00057</a></li><li>Bacci, G., Ferrari, S., and Longhi, A., et al. (2003). Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997. <em>Annals of oncology, 14</em>, 1654-9. doi: <a href="https://dx.doi.org/10.1093/annonc/mdg457">10.1093/annonc/mdg457</a></li><li>Leavey, P.J., Mascarenhas, L., Marina, N., et al. (2008). Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group. <em>Pediatric blood & cancer, 51</em>, 334-8. doi: <a href="https://dx.doi.org/10.1002/pbc.21618">10.1002/pbc.21618</a></li></ol>
Sarcome d’EwingSSarcome d’EwingEwing sarcomaFrenchOncologyPre-teen (9-12 years);Teen (13-18 years)Legs;Arm;Back;Chest;PelvisSkeletal systemConditions and diseasesAdult (19+) CaregiversNA2018-11-08T05:00:00ZAbha Gupta, MD, MSc, FRCPCHealth (A-Z) - ConditionsHealth A-Z<p>Le sarcome d’Ewing est un type de cancer qui peut apparaître dans les os et parfois dans les tissus mous. On le retrouve le plus souvent chez les enfants, les adolescents et les jeunes adultes. Renseignez-vous sur les symptômes de cette affection et sur la façon dont il peut être diagnostiqué et traité.</p><h2>Qu’est-ce que le sarcome d’Ewing?</h2><p>Le sarcome d’Ewing est un type rare de cancer qui peut toucher n’importe quel os et parfois les tissus mous. Les os les plus fréquemment touchés sont les os des jambes et des bras, le bassin, les côtes, la colonne vertébrale et le sternum. Le sarcome d’Ewing se manifeste le plus souvent chez les préadolescents, les adolescents et les jeunes adultes âgés de 10 à 20 ans. Chez les patients dont le cancer ne s’est pas propagé, le taux de survie à cinq ans est supérieur à 70 %.</p><h2>Key points</h2><ul><li>Le sarcome d’Ewing est un type rare de cancer affectant les os ou les tissus mous.</li><li>Ce sont le plus souvent les enfants, les adolescents et les jeunes adultes âgés de 10 à 20 ans qui en sont atteints.</li><li>Le symptôme le plus courant du sarcome d’Ewing est la douleur (surtout lorsqu’elle commence dans les os).</li><li>On peut d’abord penser que cette douleur est liée à un accident du sport, à des problèmes de croissance ou à un état inflammatoire.</li></ul><h2>Symptômes du sarcome d’Ewing</h2><p>Les symptômes du sarcome d’Ewing comprennent :</p><ul><li>une enflure ou une bosse à l’emplacement de la tumeur;</li><li>une douleur près de l’emplacement de la tumeur;</li><li>une douleur causée par une blessure plus forte que prévu et qui ne s’atténue pas avec le temps.</li></ul><p>Souvent, les patients vont très bien, à l’exception de l’apparition d’une bosse douloureuse.</p><h2>Quelles sont les causes du sarcome d’Ewing?</h2><p>Il n’y a actuellement aucune cause connue du sarcome d’Ewing. Cette affection n’est pas héréditaire. C’est la deuxième tumeur osseuse primaire la plus fréquente.</p><h2>Qui peut contracter le sarcome d’Ewing?</h2><p>Le sarcome d’Ewing se manifeste le plus souvent chez les préadolescents, les adolescents et les jeunes adultes âgés de 10 à 20 ans.</p><h2>Diagnostic du sarcome d’Ewing</h2><p>Au début, les symptômes du sarcome d’Ewing peuvent être diagnostiqués comme étant liés à un accident du sport, à des problèmes de croissance ou à un état inflammatoire. Toutefois, si les symptômes sont incertains, persistent ou évoluent rapidement, consultez immédiatement le médecin pour une évaluation plus approfondie.</p><p>Le médecin fera une évaluation complète des antécédents de votre enfant et un examen physique de celui-ci afin de déceler :</p><ul><li>toute présence de bosse ou enflure et leur évolution, le cas échéant;</li><li>l’intensité de la douleur et son état (constante ou croissante);</li><li>la présence d’une claudication (boitement) inexpliquée ou d’un problème de fonctionnement de ses membres.</li></ul><p>Il pourra prescrire des radiographies, une tomodensitométrie ou une IRM de la zone concernée.</p><p>Une biopsie de la masse sera également faite pour confirmer le diagnostic.</p><p>Pour vérifier si le cancer s’est propagé, une tomodensitométrie des poumons et une scintigraphie osseuse seront également effectuées.</p><h2>Traitement du sarcome d'Ewing</h2><p>Le traitement habituel du sarcome d’Ewing consiste en une chimiothérapie jumelée à une certaine forme de contrôle local. Le contrôle local comprend soit une chirurgie, soit une radiothérapie, soit les deux. La chimiothérapie, qui dure généralement de 28 à 30 semaines au total, et le contrôle local sont nécessaires pour traiter le sarcome d’Ewing. Des effets secondaires du traitement apparaissent à court et à long terme.</p><h2>Ressources</h2><p>Pour de plus amples renseignements sur le sarcome d’Ewing, consultez les ressources suivantes (disponibles uniquement en anglais) :</p><ul><li>Pour en apprendre davantage sur le sarcome d’Ewing, rendez-vous sur le site Web du <a href="https://www.cancer.gov/types/bone/patient/ewing-treatment-pdq">National Cancer Institute</a>.</li><li>Consultez un article qui explique comment <a href="http://www.sickkids.ca/aboutsickkids/newsroom/past-news/2018/bone-cancers-hidden-years-before-diagnosis.html">le cancer des os des enfants peut rester inconnu pendant des années avant le diagnostic</a>.<br></li><li>Un <a href="https://assets.aboutkidshealth.ca/AKHAssets/Ewings%20Sarcoma%20Brochure.pdf">guide à l’intention des médecins</a> fournit également des renseignements sur le sarcome d’Ewing.</li></ul><p>Cette page a été soutenue et créée en collaboration avec la <a href="https://www.sickkidsfoundation.com/campaigns/ewingscancerfoundation?appeal=SGL-TRIO-CP-ECF&utm_campaign=ewingscancerfoundation&utm_medium=web&utm_source=ecfc">Ewings Cancer Foundation of Canada</a>.</p><h2>Références</h2><ol><li>The Canadian Childhood Cancer Surveillance and Control Program. (August 2004). <em>Diagnosis and Initial Treatment of Cancer in Canadian Adolescents 15 to 19 Years of Age, 1995–2000</em>. Retrieved from <a href="http://publications.gc.ca/collections/Collection/H39-4-38-2004E.pdf">http://publications.gc.ca/collections/Collection/H39-4-38-2004E.pdf</a></li><li>Public Health Agency of Canada. (October 2017). <em>Cancer in Young People in Canada: A Report from the Enhanced Childhood Cancer Surveillance System</em>. Retrieved from <a href="https://www.canada.ca/content/dam/hc-sc/documents/services/publications/science-research-data/cancer-young-people-canada-surveillance-2017-eng.pdf">https://www.canada.ca/content/dam/hc-sc/documents/services/publications/science-research-data/cancer-young-people-canada-surveillance-2017-eng.pdf</a></li><li>George, G., and Grimer, R. (2012). Early symptoms of bone and soft tissue sarcomas: could they be diagnosed earlier? <em>Annals of The Royal College of Surgeons of England, 94</em>, 261-266. doi: <a href="https://dx.doi.org/10.1308/003588412X13171221590016">10.1308/003588412X13171221590016</a></li><li>Grimer, R.J., and Briggs, T.W. (2010). Earlier diagnosis of bone and soft-tissue tumours. <em>The Journal of bone and joint surgery. British volume, 92</em>, 1489-92. doi: <a href="https://doi.org/10.1302/0301-620X.92B11.24326">10.1302/0301-620X.92B11.24326</a></li><li>Borinstein, S.C., Beeler, N., and Block, J.J., et al. (2013). A Decade in Banking Ewing Sarcoma: A Report from the Children's Oncology Group. <em>Frontiers in oncology, 3</em>, 57. doi: <a href="https://dx.doi.org/10.3389/fonc.2013.00057">10.3389/fonc.2013.00057</a></li><li>Bacci, G., Ferrari, S., and Longhi, A., et al. (2003). Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997. <em>Annals of oncology, 14</em>, 1654-9. doi: <a href="https://dx.doi.org/10.1093/annonc/mdg457">10.1093/annonc/mdg457</a></li><li>Leavey, P.J., Mascarenhas, L., Marina, N., et al. (2008). Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group. <em>Pediatric blood & cancer, 51</em>, 334-8. doi: <a href="https://dx.doi.org/10.1002/pbc.21618">10.1002/pbc.21618</a></li></ol>

 

 

 

 

Ewing sarcoma3396.00000000000Ewing sarcomaEwing sarcomaEEnglishOncologyPre-teen (9-12 years);Teen (13-18 years)Legs;Arm;Back;Chest;PelvisSkeletal systemConditions and diseasesAdult (19+) CaregiversNA2018-11-08T05:00:00ZAbha Gupta, MD, MSc, FRCPC9.7000000000000048.0000000000000823.000000000000Health (A-Z) - ConditionsHealth A-Z<p>Ewing sarcoma is a type of cancer that can start in bone and sometimes soft tissue. It is most commonly found in children, teens and young adults. Learn about the signs and symptoms and how it is diagnosed and treated.</p><h2>What is Ewing sarcoma?</h2><p>Ewing sarcoma is a rare type of cancer which can affect any bone and sometimes soft tissue. The bones most commonly affected are the leg and arm bones, pelvis, ribs, spine and sternum. Ewing sarcoma is seen most often in pre-teens, adolescents and young adults between the ages of 10 and 20. In patients where the cancer has not spread the five-year survival rate is greater than 70%.</p><h2>Key points</h2><ul><li>Ewing sarcoma is a rare type of cancer affecting bones or soft tissue.</li><li>It is most commonly found in children, teens and young adults between ages 10 and 20.</li><li>The most common symptom of Ewing sarcoma is pain (especially when it starts in the bone).</li><li>This pain may initially be thought to be related to sports injury, growing pains or an inflammatory condition.</li></ul> <h2>Symptoms of Ewing sarcoma</h2><p>Symptoms of Ewing sarcoma include:</p><ul><li>swelling or a lump at the site of the tumour</li><li>pain near the site of the tumour</li><li>pain from an injury that is greater than expected and does not get better with time</li></ul><p>Often patients are very well except for a painful bump.</p><h2>What causes Ewing sarcoma?</h2><p>There is currently no known cause for Ewing sarcoma. It is not hereditary. It is the second most common primary bone tumour.</p><h2>Who gets Ewing sarcoma?</h2><p>Ewing sarcoma is most commonly seen in pre-teens, adolescents and young adults between the ages of 10 and 20.</p><h2>Spread of Ewing sarcoma</h2><p>Ewing sarcoma can spread or metastasize to other parts of the body. At diagnosis, one in four people will have a tumour that has spread to another part of their body. The most common site of spread is to the lungs.</p><h2>Diagnosing Ewing sarcoma</h2><p>Initially, the symptoms of Ewing sarcoma can be diagnosed as a sports injury, growing pains or an inflammatory condition. However, if symptoms cannot be fully explained, persist or change rapidly, see your doctor immediately for further assessment.</p><p>Your child’s doctor will do a complete history and physical examination that includes:</p><ul><li>if there is a lump or swelling, and whether it has changed in size</li><li>the amount of pain, whether it is constant or increasing in intensity</li><li>if there is an unexplained limp or problem using their limbs</li></ul><p>Your child’s doctor will order X-rays, a CT scan or an MRI of the area of concern.</p><p>A biopsy of the mass will be done to confirm the diagnosis.</p><p>To check to see if the cancer has spread, a CT scan of the lungs and a scan of the bones will also be done.</p> <h2>Treatment for Ewing sarcoma</h2><p>The standard treatment for Ewing sarcoma includes both chemotherapy as well as some form of local control. Local control includes either surgery or radiation or both. The chemotherapy generally lasts for 28 to 30 weeks in total. Both chemotherapy and local control are needed in order to treat Ewing sarcoma. There are both short-term and long-term side effects of the treatment.</p><h2>Resources</h2><p>For additional information about Ewing sarcoma please visit the following resources.</p><ul><li>Find more information about Ewing sarcoma at the <a href="https://www.cancer.gov/types/bone/patient/ewing-treatment-pdq">National Cancer Institute</a>.</li><li>Read an article about <a href="http://www.sickkids.ca/aboutsickkids/newsroom/past-news/2018/bone-cancers-hidden-years-before-diagnosis.html">how children’s bone cancers could remain hidden for years before diagnosis</a>.</li><li>A <a href="https://assets.aboutkidshealth.ca/AKHAssets/Ewings%20Sarcoma%20Brochure.pdf">guide for physicians</a> providing information about Ewing sarcoma.</li></ul> <figure class="asset-small"> <a href="https://www.sickkidsfoundation.com/ewingscancerfoundation"> <img src="https://assets.aboutkidshealth.ca/akhassets/Ewings%20cancer%20logo%20300.jpg" alt="" /></a> </figure> <p>This page was supported and created in collaboration with the <a href="https://www.sickkidsfoundation.com/ewingscancerfoundation">Ewings Cancer Foundation of Canada</a>.</p><h2>References</h2><ol><li>The Canadian Childhood Cancer Surveillance and Control Program. (August 2004). <em>Diagnosis and Initial Treatment of Cancer in Canadian Adolescents 15 to 19 Years of Age, 1995–2000</em>. Retrieved from <a href="http://publications.gc.ca/collections/Collection/H39-4-38-2004E.pdf">http://publications.gc.ca/collections/Collection/H39-4-38-2004E.pdf</a></li><li>Public Health Agency of Canada. (October 2017). <em>Cancer in Young People in Canada: A Report from the Enhanced Childhood Cancer Surveillance System</em>. Retrieved from <a href="https://www.canada.ca/content/dam/hc-sc/documents/services/publications/science-research-data/cancer-young-people-canada-surveillance-2017-eng.pdf">https://www.canada.ca/content/dam/hc-sc/documents/services/publications/science-research-data/cancer-young-people-canada-surveillance-2017-eng.pdf</a></li><li>George, G., and Grimer, R. (2012). Early symptoms of bone and soft tissue sarcomas: could they be diagnosed earlier? <em>Annals of The Royal College of Surgeons of England, 94</em>, 261-266. doi: <a href="https://dx.doi.org/10.1308/003588412X13171221590016">10.1308/003588412X13171221590016</a></li><li>Grimer, R.J., and Briggs, T.W. (2010). Earlier diagnosis of bone and soft-tissue tumours. <em>The Journal of bone and joint surgery. British volume, 92</em>, 1489-92. doi: <a href="https://doi.org/10.1302/0301-620X.92B11.24326">10.1302/0301-620X.92B11.24326</a></li><li>Borinstein, S.C., Beeler, N., and Block, J.J., et al. (2013). A Decade in Banking Ewing Sarcoma: A Report from the Children's Oncology Group. <em>Frontiers in oncology, 3</em>, 57. doi: <a href="https://dx.doi.org/10.3389/fonc.2013.00057">10.3389/fonc.2013.00057</a></li><li>Bacci, G., Ferrari, S., and Longhi, A., et al. (2003). Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997. <em>Annals of oncology, 14</em>, 1654-9. doi: <a href="https://dx.doi.org/10.1093/annonc/mdg457">10.1093/annonc/mdg457</a></li><li>Leavey, P.J., Mascarenhas, L., Marina, N., et al. (2008). Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group. <em>Pediatric blood & cancer, 51</em>, 334-8. doi: <a href="https://dx.doi.org/10.1002/pbc.21618">10.1002/pbc.21618</a></li></ol>https://assets.aboutkidshealth.ca/AKHAssets/Father_and_son_chatting_on_a_bench.jpgEwing sarcomaFalse